Earnings calls

Dr Lal Pathlabs concall ledger

Every earnings call for LALPATHLAB — management tone, guidance, KPIs and promise tracking, quarter by quarter.

LALPATHLAB · 6 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 06 May 2026Call held 06 May 2026

LALPATHLAB Q4 FY26 Earnings Call Transcript & Analysis

Revenue FY26₹2,763 cr+12% YoYEBITDA FY26₹752 cr+8% YoYEBITDA Margin FY2627.2%PAT FY26₹510 crPAT Margin FY2618.4%

Revenue FY26 ₹2,763 cr (+12% YoY); EBITDA FY26 ₹752 cr (+8% YoY); EBITDA Margin FY26 27.2%. Revenue for Q4 FY26 grew 16.6% YoY to ₹703 crores.

Read full transcript & analysis

Q3 FY26Published 30 Jan 2026Call held 30 Jan 2026

LALPATHLAB Q3 FY26 Earnings Call Transcript & Analysis

Revenue₹660 cr+11% YoYEBITDA₹179 cr+16% YoYEBITDA Margin27.2%PAT₹91 cr−7% YoYEPS₹5.4−7% YoY

Revenue ₹660 cr (+11% YoY); EBITDA (Pre-Exceptional) ₹179 cr (+16% YoY); EBITDA Margin (Pre-Exceptional) 27.2%. Revenue for Q3 FY26 stood at ₹660 crore, representing a 10.6% YoY growth.

Read full transcript & analysis

Q2 FY26Published 31 Oct 2025Call held 31 Oct 2025

LALPATHLAB Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹731 cr+11% YoYEBITDA Margin30.7%PAT₹152 cr+16% YoYEPS₹18.1+17% YoY

Revenue ₹731 cr (+11% YoY); EBITDA Margin 30.7%; PAT ₹152 cr (+16% YoY). Revenue for Q2 FY26 grew 10.7% YoY to ₹731 crore, with H1 revenue reaching ₹1,400 crore (+11% YoY).

Read full transcript & analysis

Q1 FY26Published 31 Jul 2025Call held 31 Jul 2025

LALPATHLAB Q1 FY26 Earnings Call Transcript & Analysis

Revenue₹670 cr+11% YoYEBITDA Margin28.7%PAT₹134 cr+24% YoYEPS₹15.9+24% YoY

Revenue ₹670 cr (+11% YoY); EBITDA Margin 28.7%; PAT ₹134 cr (+24% YoY). Revenue grew 11.3% YoY to ₹670 crore, driven by volume momentum and favorable test mix.

Read full transcript & analysis

Q4 FY25Published 25 Apr 2025Call held 25 Apr 2025

LALPATHLAB Q4 FY25 Earnings Call Transcript & Analysis

Revenue₹603 cr+11% YoYEBITDA Margin28.1%PAT₹156 cr+81% YoYEPS₹18.6+84% YoY

Revenue ₹603 cr (+10% YoY); EBITDA Margin 28.1%; PAT ₹156 cr (+81% YoY). Revenue for Q4 FY25 reached ₹603 crore, representing a 10.5% YoY growth.

Read full transcript & analysis

Q3 FY25Published 30 Jan 2025Call held 30 Jan 2025

LALPATHLAB Q3 FY25 Earnings Call Transcript & Analysis

Revenue₹597 cr+11% YoYEBITDA₹154 cr+10% YoYEBITDA Margin25.8%PAT₹98 cr+19% YoYEPS₹11.6+19% YoY

Revenue ₹597 cr (+11% YoY); EBITDA ₹154 cr (+10% YoY); EBITDA Margin 25.8%. Revenue grew 10.7% YoY to ₹597 crore, driven by volume and mix improvement without price increases.

Read full transcript & analysis